A shared feature of these compounds is a tertiary nitrogen, a common motif in many pharmacological agents that is often critical for biological activity (Supplementary Note 1) . We envisioned a general caging strategy involving covalent attachment of a coumarin 4-6 cage to form a quaternary ammonium salt. Quaternization has been used to create photoactivatable tertiary amines such as polymer initiators 7 , amino acids 8 , mustards 9 , and anticancer agents 10 , but such compounds have not been reported in biological experiments. We applied this strategy to nicotine (1), and alkylated with coumarin (8) to obtain PA-Nic (9; Fig. 1a ). PA-Nic releases nicotine when exposed to UV illumination (365 nm) with an uncaging quantum yield (Φ u ) of 0.74%, and generates coumarins 10 and 11 as byproducts, which suggests a radical-mediated photolytic mechanism ( Fig. 1a,c , Supplementary  Fig. 1a , Supplementary Note 1). The relatively low Φ u value for PA-Nic is compensated, in part, by a high extinction coefficient (ε = 17,400 M −1 cm −1 ). In our study PA-Nic showed excellent dark stability in aqueous solution (Fig. 1d) , and formation of the quaternary center at the 4-position of the coumarin elicited an unexpected ~15-nm red shift in the absorption maxima of the coumarin cage (λ max = 404 nm; Fig. 1e ), thus matching it to ~400-nm light sources. We then applied this strategy to prepare quaternary ammonium photoactivatable derivatives of compounds 2-7, which all showed photoconversion with similar Φ u values, excellent dark stability, red-shifted λ max , high ε, and the same coumarin byproducts (Supplementary Fig. 1b-k , Supplementary Note 1). We also confirmed that a quaternary center is necessary for the shift in λ max (Supplementary Fig. 1l,m) .
PA-Nic itself exhibited no nAChR-antagonist properties, and our preparations of PA-Nic were devoid of free nicotine ( Supplementary  Fig. 2h-k) . PA-Nic photolysis currents were eliminated by an nAChR-antagonist cocktail and reversed at approximately +2 mV ( Supplementary Fig. 2l-n) . Pressure-ejection application of nicotine and ACh provided calibration for PA-Nic photolysis currents ( Supplementary Fig. 2o,p) . Epi-illumination flashes elicited responses that increased in amplitude with increasing flash energy and flash duration ( Fig. 1g-j) . Thus, light-evoked nicotine release allowed the generation of complete photochemical concentration-response relations in neurons, which is an advantage over existing drug-application approaches.
Next, we determined whether PA-Nic could be used during two-photon laser scanning microscopy (2PLSM) and two-photon photolysis. The two-photon fluorescence action cross-section (δ f ; Online Methods) spectrum of PA-Nic was distinct from that of GCaMP6f (Supplementary Fig. 3a) . We measured the two-photon uncaging action cross-section (δ u ) as 0.094 Goeppert-Mayer units (GM) at the maximal two-photon absorption (810 nm) and as 0.059 GM and 0.025 GM at the commonly used 760-nm and 720-nm photolysis wavelengths, respectively 4 (Supplementary  Fig. 3b,c, Online Methods, Supplementary Note 1) . These values are similar to those for the widely used 4-methoxy-7-nitroindolinyl (MNI)-glutamate (δ u = 0.06 GM at 730 nm) 1 . PA-Nic (100 µM) photostimulation (720 nm) evoked stable inward currents, and no responses were evoked at 760-900 nm in the absence of PA-Nic ( Supplementary Fig. 3d,e) . At 760 nm, two-photon photolysis amplitudes increased with longer pulse durations at a fixed laser power or with increasing laser power at a fixed pulse duration ( Supplementary Fig. 3f,g) .
To study nAChRs in cellular compartments, we visualized MHb neuronal morphology with 2PLSM and uncaged nicotine with perisomatic one-photon laser pulses (405 nm, ~1-µm spot diameter). After confirming that moderate laser powers (1-2.5 mW, 50 ms) did not elicit currents in the absence of PA-Nic, we identified suitable photostimulation parameters by measuring the relationship between evoked currents and laser power and pulse duration (Supplementary Fig. 3h-m) . PA-Nic photolysis currents were antagonized by mecamylamine and fell to noise levels with the laser spot positioned ≥10 µm from the soma ( Fig. 2a-c) . Currents near proximal dendrites were greater than those near distal dendrites ( Fig. 2d,e ). Our results showcase the temporal and spatial precision afforded by laser flash photolysis of PA-Nic. Next, we studied the pharmacology of nAChR upregulation, a key feature of nicotine dependence. Chronic nicotine treatment upregulates nAChR function in MHb neurons 15 , including neurons that express choline acetyltransferase (ChAT) ( Supplementary Fig. 4a-d) , but it is unknown whether this reflects an increase in the number of surface receptors or a shift in nAChR sensitivity. By generating a photochemical concentration-response curve with PA-Nic, we determined that chronic nicotine exposure increased the pharmacological efficacy of acute nicotine without affecting potency ( Fig. 2f,g) . This suggests that chronic nicotine treatment increases receptor number without affecting receptor sensitivity to agonist. In laser flash recordings, uncaging responses were enhanced by chronic nicotine treatment in both somata and dendrites ( Fig. 2h,i) . Thus, chronic nicotine exposure induces plastic changes in postsynaptic nAChR function that may sensitize MHb neurons to cholinergic agonists, which could modulate excitability and/or dendritic integration. We further explored PA-Nic's utility by studying nAChRmodulated excitability and Ca 2+ mobilization. When we used a restricted field-stop aperture (Supplementary Fig. 2k ) to constrain brief (33 ms) epi-illumination flashes (~60-µm field of view), firing was transiently enhanced when nicotine was uncaged directly over the recorded neuron, but not when nicotine was uncaged 100-200 µm away from the neuron ( Supplementary  Fig. 5a,b ). Next, we examined Ca 2+ dynamics in MHb ChAT + neurons expressing GCaMP6f 16 and displaying spontaneous Ca 2+ fluctuations and responses to exogenous nicotine ( Supplementary  Fig. 5c-e ). When we applied PA-Nic locally to the imaged neuron, perisomatic flash durations of only 5 ms (405 nm; 2 mW) were sufficient to robustly increase Ca 2+ levels ( Supplementary  Fig. 5f,g) . Flashes without PA-Nic were ineffective, and nAChR antagonists significantly attenuated Ca 2+ signals induced by PA-Nic photolysis ( Supplementary Fig. 5g,h) . Together, these results show that PA-Nic can be used in electrophysiological or alloptical regimes for spatially delimited modulation of action potential firing or activity-dependent Ca 2+ increases.
Finally, we examined PA-Nic's utility in other settings. MHb ChAT + neurons project to interpeduncular nucleus (IPN), where neurons are densely surrounded by cholinergic, nAChR-bearing fibers ( Supplementary Fig. 6a,b ). PA-Nic laser flash photolysis (2 mW; 50 ms) adjacent to IPN GABAergic neurons elicited a distinct, low-amplitude but smoldering current for which peak current versus net charge was monotonic ( Supplementary  Fig. 6c-e) . In contrast to MHb responses, peak current and net charge did not decay with distance from the soma but were blocked by nAChR antagonists (Supplementary Fig. 6f -i). We then studied stratum radiatum interneurons in hippocampus, which express moderate levels of postsynaptic α7 nAChRs 17 ( Supplementary  Fig. 6j-l) . Epi-illumination photolysis of PA-Nic (0.12 mW mm −2 ; 250 ms; 2 mM PA-Nic local perfusion) efficiently activated α7, as confirmed by sensitivity to 10 nM methyllycaconitine ( Supplementary Fig. 6m,n) . These parameters (flash duration < 1 s, PA-Nic local perfusion, field-stop-aperture restricted) may be ideal for consistent activation of desensitization-prone nAChRs such as α7 or β2 receptors. Together, these experiments indicate that PA-Nic is broadly useful for examining nAChRs with varying kinetics and presynaptic or postsynaptic arrangements.
In summary, we have developed a flexible strategy for preparing photoactivatable derivatives of previously uncageable drugs. Our photoactivatable nicotine (PA-Nic; 9) can be activated by relatively short-wavelength one-photon (<470 nm) or two-photon (<900 nm) light, and thus can be imaged in combination with other fluorophores or sensors. It is now possible to finely tune the spatiotemporal distribution of an nAChR agonist during optopharmacology experiments, which allows different aspects of nicotine exposure to be modeled. PA-Nic could prove useful for studying cholinergic volume versus point-to-point transmission 18 , or in nAChR functional mapping 17 and imaging experiments in neurons where dendritic and/or presynaptic Ca 2+ dynamics are rapidly modulated by nAChRs. More generally, given the number of tertiary amine compounds in the pharmacopeia, the use of a photoscissile quaternary linkage should enable the development of other photoactivatable compounds to better model drug exposure and modulate native receptor proteins in brain tissue.
methods
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. online methods Chemical synthesis and photochemistry. Experimental details, characterization for all novel compounds, and determination of photochemical byproducts of PA-Nic photolysis can be found in Supplementary Note 1.
UV-Vis and fluorescence spectroscopy. Spectroscopy was performed using 1-cm path length, 3.5-mL quartz cuvettes from Starna Cells or 1-cm path length, 1.0-mL quartz microcuvettes from Hellma. All measurements were taken at ambient temperature (22 ± 2 °C). Absorption spectra were recorded on a Cary Model 100 spectrometer (Agilent). Fluorescence emission spectra were recorded on a Cary Eclipse (Varian). Absolute fluorescence quantum yields were recorded on a Quantaurus-QY spectrometer (model C11374; Hamamatsu). All spectroscopy measurements were performed in phosphate-buffered saline (PBS), pH 7.4, and the values of maximum absorption wavelength (λ max ), extinction coefficient at λ max (ε), maximum fluorescence emission wavelength (λ em ), and fluorescence quantum yield (Φ f ) presented are averages (n = 3; Supplementary Fig. 1k ).
HPLC and LC-MS.
High-performance liquid chromatography (HPLC) was performed on an Agilent 1200 Analytical HPLC system equipped with an autosampler and diode array detector. To measure the uncaging quantum yield (Φ u ; Fig. 1c ), we monitored the loss of PA-Nic (9) using a 4.6 × 150 mm Kinetex C18 column (Phenomenex) with a 5-95% gradient of CH 3 
To examine the release of pharmacological agents 2-7 and coumarin byproducts 10 and 11 from compounds 12-17 ( Supplementary Fig. 1 ), we assessed samples by tandem liquid chromatography-mass spectrometry (LC-MS) using an Agilent 1200 LC-MS system equipped with an autosampler, diode array detector, and mass spectrometry detector using a 4.6 × 150 mm Gemini NX-C18 column with a 5-95% or 5-50% gradient of CH 3 CN in H 2 O containing constant 0.1% (v/v) TFA. Chromatograms were measured using absorbance at 254 nm or 210 nm, or using the total ion count, depending on the optical properties of the released drug compound.
Determination of uncaging quantum yield. Photochemistry was performed in 1-cm path length, 3.5-mL quartz cuvettes (Starna) in a Luzchem LZC 4V photoreactor equipped with 365-nm UV lamps, a carousel, and a timer as previously described 19 . Briefly, the light intensity was calibrated by potassium ferrioxalate actinometry. A solution of 60 mM K 3 Fe(C 2 O 4 ) 3 was irradiated using the photoreactor setup, and released Fe 2+ was determined by complexometry with 1,10-phenanthroline. Using the known quantum yield of this process (Φ = 1.21), we determined the photon flux (I) as 3.57 × 10 −7 ein/min·cm 2 . For the conversion of PA-Nic (9) to nicotine (1), the samples were irradiated and a small aliquot (50 µL) was placed in an amber glass high-recovery HPLC vial. These samples were analyzed by HPLC as described above. We determined Φ u (mol/ein) by fitting a plot of HPLC peak integral signal (S) versus irradiation time to a one-phase exponential decay described by equation (1):
where S 0 is the signal before irradiation, t is the irradiation time (min), S t is the signal at time t, I is the irradiation (ein/min·cm 2 ),
and σ is a decadic extinction coefficient (in units of cm 2 /mol; 1,000-fold higher than the ε value with units of M −1 cm −1 based on cuvette geometry). For the conversion of compound 9 to compound 1, we obtained a Φ u value of 0.74% (Fig. 1c) . Coumarinbased cages have broad utility in the release of small-molecule modulators of biological activity [4] [5] [6] [20] [21] [22] [23] [24] ; we note that although the Φ u value for 9 was lower than those for coumarin caged molecules that release better leaving groups such as carboxylates and phosphates [4] [5] [6] 21, 23 , it was similar to the Φ u value of a 7-aminocoumarin caged compound that releases an amine via a carbamate linkage 6 . For other caged compounds, the uncaging quantum yield was determined by illumination with a 405-nm LED (LOCTITE CL20 flood array), using 9 as a standard (Supplementary Fig. 1h,  Supplementary Note 1) .
Two-photon action cross-section for fluorescence and uncaging.
We quantified the efficacy of uncaging by two-photon excitation by determining the uncaging action cross-section δ u , which is the product of the two-photon absorption cross-section (σ 2 ) and the two-photon uncaging quantum yield (Φ 2u ). In addition, as 9 is moderately fluorescent (Supplementary Fig. 1k ), we also characterized the two-photon fluorescence action cross-section δ f , which is the product of σ 2 and the two-photon fluorescence quantum yield (Φ 2 ), properties that are known for the reference dye fluorescein 25, 26 . The action cross-sections δ u and δ f are expressed in units of Goeppert-Mayer (GM), where 1 GM is defined as 10 −50 cm 4 ·s photon −1 .
To determine δ f we used the experimental setup previously described 27, 28 ; 1 µM solutions of PA-Nic (9) in PBS, GCaMP6f in 30 mM MOPS buffer, pH 7.2, containing 100 mM KCl and 10 mM Ca·EGTA, or reference dye fluorescein in 50 mM sodium borate buffer, pH 9.5, were illuminated in an epi-illumination microscope (IX-81, Olympus) with light from a mode-locked femtosecond Ti:Sapphire laser (Chameleon Ultra II, Coherent). Fluorescence collected by the 1.2-NA (numerical aperture) objective (UplanSApo 60× W; Olympus) was reflected off the laser dichroic (675DCSPXR; Omega Optical), spectrally filtered (539/278; Semrock), and focused by the tube lens onto a fiber-coupled avalanche photodiode (SPCM-AQRH-14-FC; Excelitas). The system was run under computer control to set both laser wavelength (700-1,080 nm) and power (1 mW at the sample plane), and to record and store the avalanche photodiode signal. The use of 1 mW of laser power focused with the 1.2-NA objective yielded sufficiently low laser intensity that no fluorescence was observed from the photolysis product compounds 10 and 11. At each laser wavelength, the action cross-section of PA-Nic (9) was found from equation (2):
where the subscripts S and F refer to the sample (PA-Nic or GCaMP6f) and fluorescein, respectively; Φ 2 is the two-photon fluorescence quantum yield (usually equal to the one-photon fluorescence quantum yield, Φ f ), σ 2 is the two-photon absorption cross-section in GM, 〈F(t)〉 is the fluorescence signal recorded by the detector in counts per second, η is the detector quantum efficiency averaged over the fluorescence emission spectrum, and T is the fraction of the fluorescent light transmitted through the bandpass filter. Using this equation, together with the known fluorescein two-photon absorption cross-section (average of values from refs. 25,26) and assuming Φ 2F is equal to the one-photon
fluorescein fluorescence quantum yield (Φ f = 0.92), we determined the two-photon fluorescence action cross-section spectrum of PA-Nic and GCaMP6f (Supplementary Fig. 3a,c) .
To determine the δ u of PA-Nic (9), we adapted previously described methods 4, 29 to find the fractional amount of photolysis by HPLC (Shimadzu UFLC system with diode array detector; 4.6 × 150 mm Gemini NX-C18 column with a 5-95% gradient of CH 3 CN in H 2 O containing constant 0.1% (v/v) TFA). Photolysis experiments proceeded as follows: laser light from a Ti:Sapphire laser was focused by a 50-mm focal-length achromatic doublet lens (AC254-050-B; Thorlabs) into a sub-micro cuvette (16.10F-Q-10; Starna) containing a solution of PA-Nic (10 µM, 18 µL) in PBS buffer. The solution also contained 50 µM 3-(4methoxyphenyl)propan-1-amine, a non-photolyzable internal concentration standard to correct for evaporation during the illumination period, as the sealed cuvette contained an ~180-µL head volume of air. Laser power of 0.75 W was used for all photolysis experiments, measured after transmission through the cuvette. As a diagnostic, a side-observing fiber-coupled spectrometer was set up to monitor the fluorescence spectrum of the PA-Nic solution in the cuvette during excitation. This allowed observation of spurious back-scattering effects from the PA-Nic solution that interrupted laser mode-locking, evidenced by abrupt disappearance of PA-Nic fluorescence. A quarter-wave plate placed between the laser and focusing lens was found sufficient to eliminate the spurious effects on laser mode-locking. To obtain the photolysis rate, we illuminated PA-Nic samples for various time intervals from 0 to 40 min at 810 nm, 760 nm, or 720 nm and analyzed them by HPLC as described above (n = 3; Supplementary Fig. 3b) . To obtain the spectral dependence of photolysis, we illuminated solutions of PA-Nic for 40 min at wavelengths between 710 nm and 930 nm and then analyzed them by HPLC. To determine the δ u of PA-Nic, we again used fluorescein as an external standard, which allowed δ u to be expressed according to equation (3) 4,29 :
where Φ 2u and σ 2S are the two-photon uncaging quantum yield and absorption cross-section, respectively, of PA-Nic; N p is the rate of uncaging in molecules per second as determined by HPLC; C S is the initial concentration of PA-Nic; C F is the concentration of fluorescein; 〈F(t)〉 is the time-averaged rate of fluorescence (photons per second), collected by a power detector with collection efficiency Ω; and Φ 2F and σ 2F are the two-photon fluorescence quantum yield and two-photon absorption cross-section, respectively, of fluorescein. For determination of 〈F(t)〉 F , fluorescein in 50 mM sodium borate buffer, pH 9.5, was placed in a cuvette (3-Q-10; Starna) and illuminated at 810 nm, 760 nm, or 720 nm with focused laser light (0.75 W) as above, and a sideobserving power meter (PM100A console, S120C head; Thorlabs) was used to record the fluorescent power produced. To eliminate scattered laser light, we placed an infrared-blocking filter (720/SP; Semrock) in front of the detector. The fraction of the total fluorescent power collected by the power meter is given by equation (4) 4 :
where r is the radius of the power meter (4.85 mm), R is the distance from the fluorescence axis to the detector face (45 mm), y is the measured filter transmission (0.97), and n is the refractive index of water (1.33). The δ u of PA-Nic was determined to be 0.094 GM at 810 nm, 0.059 at 760 nm, and 0.025 GM at 720 nm. The value at 810 nm was used to set the scale for converting the spectrum of photolysis versus excitation to a spectrum of uncaging action cross-section, the shape of which agreed with the fluorescence action cross-section ( Supplementary Fig. 3c) , reflecting the spectral dependence of the underlying two-photon absorption cross-section.
Reagents for neurobiology experiments. QX-314, CNQX, SR16584, and D-AP5 were obtained from Tocris. RuBi-Nic was obtained from Abcam. α-conotoxin MII was synthesized as previously described 30, 31 . ACh, mecamylamine (mec), atropine, picrotoxin, dihydro-β-erythroidine, and all other chemicals were obtained from Sigma unless otherwise specified.
Mice. An animal study protocol pertaining to this study (#IS00003604) was reviewed and approved by the Northwestern University Institutional Animal Care and Use Committee. Procedures also followed the guidelines for the care and use of animals provided by the National Institutes of Health Office of Laboratory Animal Welfare. Mice were housed at 22 °C on a 12-h light/dark cycle with food and water ad libitum. Mice were weaned on postnatal day 21 and housed with same-sex littermates. Unless stated otherwise, experiments were conducted on C57BL/6J mice obtained from Jackson Laboratories (Jax #000664). ChAT-IRES-Cre 32 (Jax #006410) (ChAT-Cre) and Ai14 (ref. 33) (Jax #007914) mouse strains were crossed to yield ChAT-Cre::Ai14 mice, which express tdTomato in a Cre-dependent manner (i.e., in neurons with an active ChAT promoter). Expression of tdTomato in MHb ChAT + neurons was confirmed in these mice via immunohistochemistry and confocal microscopy (Supplementary Fig. 2d ). We created GAD2-Cre::Ai14 mice, which express tdTomato in GAD2 + neurons, by crossing Ai14 mice to GAD2-IRES-Cre 34 (Jax #010802) (GAD2-Cre). Pre-weanling mice (<21 d old) were used for stratum radiatum recordings. All other mice used were 8-24 weeks old.
Stereotaxic injection surgery. AAV5.CAG.Flex.GCaMP6f. WPRE.SV40 vectors for Cre-dependent expression of GCaMP6f were obtained from University of Pennsylvania Vector Core (lot #V5532L, titer 1.74 × 10 13 GC/mL). Male and female ChAT-Cre mice were used for surgery starting at 8 weeks of age. Mice were initially anesthetized with an intraperitoneal (i.p.) injection of a ketamine-xylazine mixture (120 mg/kg ketamine, 16 mg/kg xylazine). Mice were given additional 'boost' injections of ketamine (100 mg/kg i.p.) as needed. Alternatively, some mice were anesthetized with isoflurane: 3% (flow rate 500 mL/min) for induction and 1.5% (28 mL/min) for maintenance. Mice were secured in a stereotaxic frame and a small incision at the top of the head was made to expose the skull. Coordinates used for bilateral MHb injections were (relative to bregma, in millimeters) mediallateral (M/L), ±0.3; anterior-posterior (A/P), −1.58; dorsal-ventral (D/V), −2.75 with overshoot to −3.0 before retraction to −2.75. Exact coordinates were adjusted to account for slight differences in head size between individual mice: the bregma/lambda distance measured for each mouse was divided by the reported bregma/lambda distance for C57 mice (4.21), then multiplied by the A/P coordinate. The injection needle was slowly lowered through the drilled hole to the D/V coordinate. For adenoassociated viruses, 300 nL of virus (per hemisphere) was infused at a rate of 50 nL/min. The injection needle was left in place for 10 min after the infusion ended before being slowly retracted. Sutures were used to close the incision. At the conclusion of the surgery, mice were given ketoprofen (5 mg/kg by subcutaneous injection) and placed in a recovery cage, kept warm, and observed until they were ambulatory. Mice were single-housed after virus injection surgery and were given at least 14 d to recover and for the virus to express before experimental procedures were started.
Chronic nicotine treatment. Mice were treated with nicotine via drinking water as previously described 35 , with minor modifications. Nicotine hydrogen tartrate or L-tartaric acid (control group) was dissolved in tap water (pH 7.0) supplemented with saccharin sodium (3 mg/mL) to mask the bitter taste of nicotine. We used the following treatment schedule (nicotine (reported as nicotine free base), tartaric acid; in µg/mL): days 1-2, (50, 75); days 3-4, (100, 150); day 5 and beyond, (200, 300). On day 5 and beyond we maintained doses by replacing drinking water solutions every 2-3 d, and mice were treated for at least 28 d before experimentation. We previously demonstrated upregulation of nAChR function in MHb VI neurons by using a different chronic nicotine exposure method: subcutaneous osmotic minipump implantation 15 . Therefore, we validated this result with the nicotine drinking water method in C57BL/6 mice ( Supplementary Fig. 4a,b) before conducting PA-Nic uncaging experiments coupled with chronic nicotine studies on ChAT-Cre::Ai14 mice ( Supplementary  Fig. 4c,d, Fig. 2f-i) .
Brain slice preparation.
For epi-illumination and 405-nm laser uncaging, brain slices were prepared as previously described 36 . Mice were anesthetized with Euthasol (sodium pentobarbital, 100 mg/kg; sodium phenytoin, 12.82 mg/kg) before trans-cardiac perfusion with oxygenated (95% O 2 /5% CO 2 ), 4 °C N-methyl-dglucamine (NMDG)-based recovery solution that contained (in mM) 93 NMDG, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 10 MgSO 4 ·7H 2 O, and 0.5 CaCl 2 ·2H 2 O; 300-310 mOsm, pH 7.3-7.4. Brains were immediately dissected after the perfusion and held in oxygenated, 4 °C recovery solution for 1 min before a brain block containing the MHb was cut and the brain was sectioned with a vibratome (VT1200S; Leica). Coronal slices (250 µm) were sectioned through the MHb (Supplementary Fig. 2b) Figure 2f only, slices containing ventral tegmental area (~bregma −3.5 mm) were prepared.
For two-photon uncaging, brain slices were prepared as follows. Animals were deeply anesthetized by inhalation of isoflurane and decapitated, and the brain was rapidly removed and immersed in ice-cold oxygenated artificial cerebrospinal fluid (ACSF) containing (in mM) 127 NaCl, 2.5 KCl, 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 2.0 CaCl 2 , 1.0 MgCl 2 , and 25 glucose (osmolarity ~310 mOsm/L). Tissue was blocked and transferred to a slicing chamber containing ice-cold ACSF, supported by a small block of 4% agar. Bilateral 250-µm-thick slices containing the MHb were cut on a Leica VT1000S and transferred to a holding chamber with ACSF equilibrated with 95% O 2 , 5% CO 2 . Slices were incubated at 34 °C for 15-30 min before electrophysiological recording.
UV-Vis nicotine uncaging. Brain slices were transferred to a recording chamber while being continuously superfused at a rate of 1.5-2.0 mL/min with oxygenated 32 °C recording solution. The recording solution contained (in mM) 124 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 24 NaHCO 3 , 12.5 glucose, 2 MgSO 4 ·7H 2 O, and 2 CaCl 2 ·2H 2 O; 300-310 mOsm, pH 7.3-7.4. Picrotoxin (100 µM), CNQX (20 µM), and D-AP5 (50 µM) were added during MHb subcellular uncaging experiments; these three drugs plus TTX (0.5 µM) were added during IPN subcellular uncaging experiments. Holding potential for voltage-clamp recordings during epi-illumination or one-photon laser flash photolysis was −60 mV, except that recordings in stratum radiatum involved pooling responses from cells held at −60 mV and −70 mV. TEA (5 mM) was added to the recording solution when the holding potential was 0 mV. Patch pipettes were pulled from borosilicate glass capillary tubes (1B150F-4; World Precision Instruments) using a programmable microelectrode puller (P-97; Sutter Instrument). Tip resistance ranged from 4.5 to 8.0 M when filled with internal solution. The following internal solution was used (in mM): 135 potassium gluconate, 5 EGTA, 0.5 CaCl 2 , 2 MgCl 2 , 10 HEPES, 2 MgATP, and 0.1 GTP; pH adjusted to 7.25 with Tris base; osmolarity adjusted to 290 mOsm with sucrose. For subcellular uncaging, this internal solution also contained QX-314 (2 mM) for improved voltage control. We recorded from neurons in the ventral 50-60% of the MHb, as previously described 12, 15 .
For epi-illumination uncaging experiments, a Nikon Eclipse FN-1 upright microscope equipped with infrared and visible differential interference contrast optics and a 40×/0.80-NA objective was used to visualize cells within brain slices. A computer running pCLAMP 10 software (Molecular Devices) was used to acquire whole-cell recordings along with an Axopatch 200B amplifier and a 16-bit Digidata 1440 A/D converter (both from Molecular Devices). Data were sampled at 10 kHz and low-pass filtered at 1 kHz. Immediately before gigaseal formation, the junction potential between the patch pipette and the superfusion medium was nulled. Series resistance was uncompensated. An LED light source (XCite 110LED; Excelitas) coupled to excitation filters (400/40 nm, 470/40 nm, and 560/40 nm bandpass) was used for photostimulation. Internal LEDs in the XCite 110LED were (center wavelength/ full-width at half-maximum, in nm) 385/30, 470/40, 560/80, and 640/40. For near-UV photostimulation, flash wavelength was therefore approximately 390 ± 10 nm. Light flashes were triggered by pCLAMP via TTL pulses. Flash energy output from the LED was determined by calibration using a photodiode power sensor (Model S120C; Thor Labs).
Some experiments involved recording inward currents after pressure-ejection application of drug to the recorded cell using a drug-filled pipette, which was moved to within 20-40 µm of the recorded neuron using a micromanipulator. Using a Picospritzer (Parker Hannifin), a pressure ejection dispensed drug (dissolved in the same superfusion medium used on the slice) onto the recorded neuron. Ejection volume, duration, and ejection pressure varied depending on whether a short (milliseconds) or long (seconds) pulse was required. The change in amplitude between the baseline and the peak was measured. Atropine (1 µM) was present in the superfusion medium when ACh was used to prevent activation of muscarinic ACh receptors. To prevent stray light from prematurely uncaging nicotine inside the drug pipette, we restricted the field stop aperture on the microscope, and retracted the drug pipette from the cell immediately after the application.
For focal nicotine uncaging using one-photon laser (405 nm) flash photolysis, an Olympus BX51 upright microscope with a 60×/1.0-NA objective was used to visualize cells. Prairie View 5 (Bruker Nano) software was used for acquisition via a Multiclamp 700B patch-clamp amplifier (Molecular Devices). Analog signals were sampled at 5 kHz and low-pass filtered at 1 kHz, and an A/D converter (PCI-NI6052e; National Instruments) was used for digitization. Patch-clamp recordings were carried out using the internal solution mentioned above, except that Alexa Fluor 568 (50 µM) or Alexa Fluor 488 (100 µM) was also included in the recording pipette to visualize cells in 2PLSM. After break-in, the internal solution with the Alexa Fluor dye was allowed to equilibrate for 15-20 min before imaging was initiated. The vast majority of 2PLSM one-photon uncaging experiments used Alexa Fluor 488 and a Mai Tai HP1040 (Spectra Physics) tuned to 900 nm, whereas several pilot studies used Alexa Fluor 568 and a Mira 900 (Coherent) infrared laser (with Verdi 10W (532-nm) pump laser) tuned to 790 nm. The laser was pulsed at 80 MHz (Mai Tai HP) or 76 MHz (Mira) (<100-fs or ~250-fs pulse duration, respectively), and a Pockels cell (ConOptics) was used for power attenuation. The dual-channel, two-photon fluorescence was detected by two non-descanned detectors; green and red channels (dual-emission filters: 525/70 nm and 595/50 nm) were detected by the following Hamamatsu photomultiplier tubes, respectively: end-on GaAsP (7422PA-40) and side-on multi-alkali (R3896). A 405-nm continuous wave laser (100 mW OBIS FP LX; Coherent) was used for photostimulation/uncaging via a second set of x-y galvanometers incorporated into the scanhead (Cambridge Technologies). A spot diameter of ~1 µm was used for all such laser flash photolysis experiments. 405-nm laser power was measured below the sample but above the condenser using a Field Master GS (LM10 HTD sensor head). A validation study on MHb neurons was conducted with the 405-nm laser in the absence of PA-Nic to identify any laser-pulse-associated artifacts (current deflections) in the voltage-clamp record. Small (<10 pA) inward currents were detected in several MHb cells when they were stimulated with 4-5 mW pulses (50 ms) but not at <2.5 mW (Supplementary Fig. 3h,i) , so laser pulses in this study did not exceed 2 mW.
PA-Nic was applied (40-80 µM in 5 mL) via superfusion to the slice with a recirculating perfusion system to conserve compound. For some MHb recordings, all MHb Ca 2+ imaging, and all hippocampus recordings, local perfusion of PA-Nic (2 mM) was used. For such studies, a glass pipette with a large diameter (20-40 µm) was back-filled with PA-Nic (2 mM) dissolved in ACSF and was connected to a pressure-ejection device. The PA-Nic-filled pipette was maneuvered to within ~50 µm of the recorded neuron, and perfusion was triggered with a constant, low pressure (1-2 p.s.i.). Prairie View 5 software was used to select spots in the field of view for focal uncaging of nicotine via 405-nm laser light flashes.
Typical flash durations were 5-50 ms (unless otherwise stated), as selected after an analysis of the relationship between pulse duration and nAChR activation ( Supplementary Fig. 3l,m) .
Two-photon Ca 2+ imaging with UV-Vis nicotine uncaging.
MHb neurons from ChAT-Cre mice infected with AAV5.CAG. Flex.GCaMP6f.WPRE.SV40 vectors were identified by twophoton excitation of GCaMP6f (920 nm, ~250-fs pulse duration, 2-3.5 mW) with a 60×/1.0-NA objective. Time-lapse images (0.074-µm 2 pixels, 2-µs pixel dwell time, 6× optical zoom, 0.65-s sampling rate) were acquired from GCaMP6f-expressing neurons that spontaneously oscillated between high and low Ca 2+ (Supplementary Fig. 5d) ; neurons not showing this behavior were not selected for imaging. Spontaneously active neurons (n = 5) were tested for responsiveness to nicotine via superfusion of 100 µM nicotine (Supplementary Fig. 5e ). For time-lapse images, we quantified the changes in Ca 2+ by calculating the mean pixel intensity along a two-dimensional (line scan) region of interest crossing the soma. For Ca 2+ imaging experiments involving PA-Nic laser flash photolysis, PA-Nic (2 mM) was locally perfused as described above. Somatic changes in Ca 2+ before and after PA-Nic photolysis were recorded with a continuous line scan. The GCaMP6f line-scan signal was acquired at 0.33 ms per line and 90 pixels per line with 0.08-µm pixels and 2-µs pixel dwell. Fluorescence intensity values were acquired from the soma and recorded as the mean of 11 pixels from the line scan. The line scan was initiated 5 s before the triggered laser flash (405 nm, 5 ms, 2 mW) and continued for 15 s after the light flash. Line scan data were processed with a 21-point moving average before analysis. Ca 2+ flux was expressed as the change in fluorescence from baseline (∆F/F 0 ), as described in equation (5):
where F 0 is the baseline GCaMP6f signal, calculated as the mean signal from the 2 s before photostimulation, and ∆F is the change in fluorescence, calculated as the difference between the peak response (F P , the mean signal from a 1-s window starting 4 s after photostimulation) and F 0 . 
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Experimental design 1. Sample size
Describe how sample size was determined.
Due to the absolute novelty of PA-Nic, sample sizes were not determined prior to experimentation. We were guided by prior studies, cited in the Online Methods, for sample size expectations.
Data exclusions
Describe any data exclusions.
Outlier data points were removed (rarely) via the ROUT method as described in the Online Methods.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
All experiments were independently replicated. Where samples were taken from animals, every reasonable effort was made to replicate findings in more than one animal.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Where applicable, animals were randomly assigned to experimental groups via informal randomization.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For chronic nicotine treatments, investigators performing recordings were blind to the treatment during the first ~50% of data collection to assure unbiased results.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
